Price: $399.99 for Pharmacology Review | $599.99 for PANRE Review
Access: Immediate digital access upon purchase
Deliverables: 12 Hours of AAPA Category 1 CME (Pharmacology) or 100 Hours of AAPA Category 1 CME (PANRE Review)
Add-ons: Amazon or Apple Gift Cards available from $100 to $1500
Maintaining your certification and state licensure requires a strategic approach to continuing medical education (CME). For Physician Assistants (PAs) and Nurse Practitioners (NPs), pharmacology credits are often the most scrutinized portion of a CME portfolio. The NCCPA and state nursing boards have specific requirements that must be met to ensure you remain eligible to practice and prescribe.
However, many clinicians fall into predictable traps when selecting and logging their pharmacology hours. These errors can lead to rejected credits, failed audits, and unnecessary stress during the recertification cycle. Understanding the nuances of AAPA Category 1 credit is essential for a smooth professional journey.
One of the most frequent errors is assuming that any lecture or course mentioning a medication qualifies as a pharmacology credit. For a course to count toward your pharmacology requirements: especially for NPs in states with strict prescriptive authority rules: the content must focus on the pharmacokinetics, pharmacodynamics, dosing, and contraindications of the drugs.
A general lecture on "Managing Hypertension" might provide Category 1 credits, but if the content is 90% diagnostic criteria and only 10% medication management, it may not meet the threshold for a "pharmacology hour." Our Pharmacology Review Course is specifically designed to meet these rigorous standards, ensuring that every hour you spend is high-yield and credit-worthy.
PAs must earn a specific amount of Category 1 CME to maintain NCCPA certification. While PAs can use AMA PRA Category 1 Credit™ from ACCME-accredited providers, many clinicians mistakenly believe that any "medical education" counts as Category 1.
Category 2 CME consists of elective activities like reading journals or precepting students. While valuable, these do not fulfill the core 50-hour Category 1 requirement for each two-year NCCPA cycle. When you choose the PANRE Review Course, you are guaranteed 100 hours of AAPA Category 1 credit, which more than covers your biannual requirement.
Many states now mandate specific CME topics for clinicians with prescriptive authority. These often include:
If you simply accumulate 12 hours of general pharmacology, you might still be out of compliance with your state board if you missed these specific mandates. It is critical to align your pharmacology review with the NCCPA Blueprint and your state’s specific requirements. Our content, written by physician assistants for physician assistants, addresses these core clinical competencies across Emergency Medicine, Family Medicine, and Internal Medicine.
CME budgets are a professional benefit, yet many clinicians fail to maximize the value of their CME money. A common mistake is buying a "bare-bones" course and then paying out-of-pocket for educational tools like tablets or medical reference books.
We offer an efficient way to use your CME money. By selecting a CME with Gift Card package, you can add an Amazon or Apple Gift Card (ranging from $100 to $1500) to your purchase. This allows you to enrich your education by purchasing the hardware or textbooks you need to stay current in your practice, all while earning your necessary AAPA Category 1 credits.
Question 1
Your patient is a 64-year-old male with a history of chronic kidney disease (Stage 3) and new-onset atrial fibrillation. His HR is 112 bpm, and BP is 138/84 mmHg. You are considering anticoagulation. Which of the following statements regarding the use of Dabigatran (Pradaxa) in this patient is correct?
A. It is a direct factor Xa inhibitor.
B. Dose adjustment is required based on creatinine clearance.
C. It requires routine monitoring of the INR.
D. It is the preferred agent for patients with mechanical heart valves.
Answer: B. Dose adjustment is required based on creatinine clearance.
Dabigatran is a direct thrombin inhibitor (not Factor Xa). It is predominantly cleared by the kidneys, necessitating dose reductions or avoidance in patients with significant renal impairment (typically CrCl < 30 mL/min). Unlike warfarin, it does not require INR monitoring. Direct oral anticoagulants (DOACs) like Dabigatran are contraindicated in patients with mechanical heart valves.
Question 2
Your patient is a 28-year-old female presenting with symptoms of a urinary tract infection. She has a history of a "severe" allergy to penicillin, described as hives and respiratory distress. Which of the following antibiotics should be avoided due to potential cross-reactivity?
A. Nitrofurantoin
B. Ciprofloxacin
C. Cephalexin
D. Fosfomycin
Answer: C. Cephalexin.
Cephalexin is a first-generation cephalosporin. While the rate of cross-reactivity between penicillins and cephalosporins is lower than previously thought (approximately 1-3%), it is still a risk in patients with a history of Type 1 hypersensitivity reactions (IgE-mediated) such as hives, angioedema, or anaphylaxis. Nitrofurantoin, Ciprofloxacin (a fluoroquinolone), and Fosfomycin do not share the beta-lactam ring and are safe alternatives regarding penicillin allergy.
Question 3
Your patient is a 52-year-old male with Type 2 Diabetes Mellitus and established atherosclerotic cardiovascular disease (ASCVD). His HgbA1c is 8.2% despite lifestyle modifications and Metformin 1000mg BID. Which of the following medication classes is the most appropriate next step to reduce his cardiovascular risk?
A. DPP-4 inhibitors
B. Sulfonylureas
C. SGLT2 inhibitors
D. Meglitinides
Answer: C. SGLT2 inhibitors.
In patients with Type 2 Diabetes and established ASCVD, SGLT2 inhibitors (like Empagliflozin) or GLP-1 receptor agonists (like Liraglutide) have been proven to provide significant cardiovascular benefits, including a reduction in major adverse cardiovascular events (MACE). Sulfonylureas and Meglitinides carry a higher risk of hypoglycemia and do not offer the same cardioprotective benefits. DPP-4 inhibitors are generally weight-neutral and have not shown the same level of ASCVD risk reduction.
To avoid the pitfalls of inefficient CME logging and ensure you are prepared for the PANRE or PANRE-LA, you need a high-yield, structured review. Our packages are tailored for the modern PA.
The PANRE Review Course is the most efficient way to secure your required credits while mastering the NCCPA Blueprint.
For those specifically needing pharmacology hours for state licensure or NP prescriptive authority, the Pharmacology Review Course provides a focused clinical deep-dive.
Avoid the common mistakes of under-counting pharmacology hours or choosing low-yield CME. Invest in a course that provides the clinical rigor you need and the AAPA Category 1 credit you require.
Price: $800 - $3,000 (depending on gift card add-on)Access: Lifetime access to course materialsDeliverables: 100…
Course: PANRE Review Course Price: Starting at $399.99 Access: 30 Months of Full Access Deliverables:…
For many Physician Assistants, the end of the fiscal year or the approach of a…
Preparing for the Physician Assistant National Recertification Exam (PANRE) is a significant undertaking that requires…
Maintaining certification requires a strategic approach to Continuing Medical Education (CME). For Physician Assistants, the…
Price: $599 - $2,500 (depending on gift card add-on selection)Access: LifetimeCredits: 100 Hours of AAPA…